Amanta Healthcare IPO Listing Ahead! Check IPO GMP Today, Subscription Details, Other Info

Amanta Healthcare IPO Listing: Days after receiving tremendous response from primary market investors, Amanta Healthcare's initial public offering (IPO) is all set to debut on the Indian stock market. Its listing is expected on Tuesday, September 9. Amanta Healthcare IPO was subscribed 82.6 times, and its latest GMP (grey market premium) stood at Rs 9 per share, according to investorgain.com.

As investors are eagerly waiting for Amanta Healthcare's IPO listing day performance, here are all the details you need to know about the healthcare company's IPO, its subscription percentage, IPO GMP today and other details.

Amanta Healthcare IPO GMP Today

Amanta Healthcare IPO GMP stood at Rs 9 per indicating a listing at Rs 135 per share (including cap price and latest GMP), according to investorgain.com. The IPO is expected to see a percentage gain/loss per share of 7.14%. The IPO's lowest GMP stood at Rs 0 per share, and the highest GMP stood at Rs 28 per share.

Amanta Healthcare IPO Subscription Details

The issue was subscribed to around 82.6 times during the period. Amanta Healthcare IPO opened for subscription on September 1 and concluded on September 3. The IPO was subscribed to around 54.96 times in the retail category, 35.86 times in the QIB category and 209.4 times in the NII category till day 3, ie September 3.

Amanta Healthcare IPO Details

The IPO is a book build issue of Rs 126 crores and is an entirely fresh issue of 1 crore shares of Rs 126 crores. The IPO allotment was finalised on September 4 and it will be listed on the BSE and NSE.

The company had fixed a price band at Rs 126 per share. The IPO's lot size for an application stood at 119. Its minimum amount of investment required by a retail is Rs 14,994 crore. Its lot size investment for sNII is 14 lots, equivalent to Rs 2,09,916 and for bNII it is 67 lots, equivalent to Rs 10,04,598.

Amanta Healthcare IPO: What Experts Have To Say About The IPO

Ventura, in its note, has recommended investors to 'Subscribe' to Amanta Healthcare IPO. "A key unique selling proposition (USP) is their SteriPort brand for large volume parenterals (LVPs), which features a two-port design, enhancing patient safety and meeting market demands for IV fluid administration," noted Ventura in its report.

Amanta Healthcare's market capitalisation post listing is expected to be Rs 489.25 crore, according to the Ventura report. Brokerage 'Scoop Investment' has also recommended investors to 'Subscribe for Long Term' duration.

The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.